National Institutes of Health is financing a delivery method for gene-editing therapies to blood-forming stem cells with natural lipid bubbles instead of viruses. . . . → Read More: Small Biz Grant Funds Non-Viral Gene Editing Delivery
|
|||||
National Institutes of Health is financing a delivery method for gene-editing therapies to blood-forming stem cells with natural lipid bubbles instead of viruses. . . . → Read More: Small Biz Grant Funds Non-Viral Gene Editing Delivery A developer of therapies derived from stem cells to replace malfunctioning islet cells in people with type 1 diabetes was acquired by Vertex Pharmaceuticals. . . . → Read More: Diabetes Cell Therapy Biotech Acquired in $320M Deal Researchers analyzed medical and scientific databases with algorithms to identify eight previously unreported biomarkers contributing to neurodegeneration similar to ALS. . . . → Read More: AI Analytics Find New ALS Genetic Drug Targets A study shows implanted lab-grown pieces of human 3-D kidney tissue can demonstrate chemical activity of drugs in preclinical tests with lab rats. . . . → Read More: Human Organoids Show Drug Activity in Lab Animals A patient in a clinical trial received an implant made of three-dimensional printed tissue to replace a deformed ear caused by microtia, a congenital condition. . . . → Read More: Trial Demonstrates 3-D Printed Ear Tissue Implant A developer of stem cell therapies for neurological disorders is receiving an $8 million grant to advance a treatment for a common type of epilepsy. . . . → Read More: Grant Funds Epilepsy Stem Cell Therapy Trial A company developing implants that release cell therapies is collaborating with a producer of regenerative stem cells to dispense insulin for people with diabetes. . . . → Read More: Companies Partner on Implanted Diabetes Beta Cell Device Early results from a clinical trial show an experimental gene transfer therapy largely reduces painful events from sickle cell disease for one to two years. . . . → Read More: Trial Shows Gene Therapy Results with Sickle Cell Disease A California state agency is helping fund a clinical trial testing an immunotherapy combined with a cancer-killing virus to treat solid tumor cancers. . . . → Read More: State Grant Funds Virus-Immunotherapy Cancer Trial A new biotechnology company has begun developing gene therapies aimed at reprogramming cells damaged by the aging process. . . . → Read More: Biotech Start-Up Begins Longevity Therapy Work |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |